CNTNAP2-AS1

Across TCGA pan-cancer cohorts, CNTNAP2-AS1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated CNTNAP2-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher CNTNAP2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CNTNAP2-AS1 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUAD show a favorable association.

BLCA, LUAD, and GBM are the cancer types where CNTNAP2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	III,IV	0.850	0.199	.012	42	view →
LUAD	DFS	Tertile	All	0.932	0.743	.007	42	view →
GBM	DFS	Tertile	All	0.481	0.175	.001	18	view →
KIRC	DFS	Tertile	IV	0.334	0.640	.016	18	view →
HNSC	OS	Tertile	III,IV	0.270	0.683	.005	18	view →
CHOL	DFS	Tertile	All	0.037	0.486	.001	18	view →
THCA	OS	Tertile	III,IV	0.875	0.988	.002	18	view →
LIHC	OS	Tertile	III,IV	0.362	0.758	.018	18	view →
ESCA	OS	Quartile	III,IV	0.676	0.343	.025	15	view →
ACC	DFS	Tertile	All	0.132	0.581	.003	15	view →
READ	OS	Tertile	II,III,IV	0.197	0.670	.028	9	view →
COAD	DFS	Tertile	IV	0.280	0.502	.024	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

CNTNAP2-AS1–BLCA (OS)

Open the BLCA breakdown →